Updates on the European Open-Label, Phase 2, Multicenter Feasibility Study of Manualized MDMA-Assisted Therapy in Subjects with PTSD

After more than 6 months of searching for suitable PTSD patients, we are very happy to report that the team at the research site in Klecany, Czech Republic, have successfully enrolled and treated their first participant in the last few weeks. 

In July, the first 2 participants enrolled at the Leiden study site in the Netherlands completed their last study visit. This site and others in Maastricht, the Netherlands, and Moss, Norway, continue to screen.

Finally, good progress is being made with contracting and study set-up at 5 study sites in Germany (2), the UK (2) and Portugal, with most on track to begin patient recruitment before the end of summer 2021.